financetom
Business
financetom
/
Business
/
XTI Aerospace Stock Is Gaining Wednesday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
XTI Aerospace Stock Is Gaining Wednesday: What's Going On?
Jun 11, 2025 10:48 AM

XTI Aerospace, Inc. ( XTIA ) shares are trading higher Wednesday after the company announced it appointed former Paramount Group CEO Stephen Griessel to its advisory board.

What To Know: The company said Griessel brings more than four decades of leadership experience across defense, aerospace and investment sectors. He currently leads Copperstone Capital Partners and previously served as Group CEO of Paramount, a global defense OEM with operations in over 25 countries.

XTI said the appointment comes as it moves to expand its footprint in both commercial and defense markets for vertical takeoff and landing (VTOL) aircraft.

"Steve's proven ability to transform defense enterprises into globally scaled OEMs will directly accelerate XTI's push into mission-critical markets," said Scott Pomeroy, CEO and Chairman of XTI.

See Also: American Superconductor Cashes In On Stock Rally, Raises $115.5 Million Via Equity Offering

XTI Price Action: At the time of writing, XTI shares are trading 79% higher at $5.46, according to data from Benzinga Pro.

Image: This illustration was generated using artificial intelligence via Midjourney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Zimmer Biomet lowers 2025 profit forecast on acquisition costs, tariff uncertainty
Zimmer Biomet lowers 2025 profit forecast on acquisition costs, tariff uncertainty
May 26, 2025
May 5 (Reuters) - Zimmer Biomet Holdings ( ZBH ) on Monday lowered its full-year adjusted profit forecast, as the medical device maker anticipates a hit from its recent acquisition of Paragon 28, currency volatility, and proposed tariffs. Investors and analysts are closely monitoring how medical device makers will handle any impact from the Trump administration's tariffs and whether they...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
BRIEF-Lamar Advertising Acquires Premier Outdoor Media
BRIEF-Lamar Advertising Acquires Premier Outdoor Media
May 26, 2025
May 5 (Reuters) - Premier Outdoor Media: * LAMAR ADVERTISING ACQUIRES PREMIER OUTDOOR MEDIA * LAMAR ADVERTISING CO ( LAMR ) - FINANCIAL TERMS OF LAMAR-PREMIER DEAL NOT DISCLOSED Source text: Further company coverage: ...
Aptose Provides Clinical Update for Tuspetinib-based Triple Drug Therapy in Tuscany Trial
Aptose Provides Clinical Update for Tuspetinib-based Triple Drug Therapy in Tuscany Trial
May 26, 2025
07:34 AM EDT, 05/05/2025 (MT Newswires) -- Aptose Biosciences ( APTOF ) on Monday reported the most recent data from its Phase 1/2 Tuscany trial in four newly diagnosed acute myeloid leukemia (AML) patients. The patients are being dosed with a 40 mg or 80 mg dose of Aptose's candidate tuspetinib together with standard of care dosing of the anti-cancer...
Copyright 2023-2026 - www.financetom.com All Rights Reserved